Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 1/20 | 0.38 |
| ▸ | CA2 | P00918 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.33 |
| ▸ | ZDHHC7 | Q9NXF8 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.31 |
| ▸ | TSHR | P16473 | 2/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | CASP7 | P55210 | 1/20 | 0.31 |
| ▸ | MGAM | O43451 | 1/20 | 0.30 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
| ▸ | SI | P14410 | 1/20 | 0.30 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8520065 | 0.84 | — | — | |
| SCHEMBL807407 | 0.84 | — | — | |
| SCHEMBL25600153 | 0.84 | — | — | |
| SCHEMBL23130165 | 0.83 | ALDH1A1 (0.39) | SMN1; SMN2ALDH1A1TSHRMGAMGAA | |
| SCHEMBL24950448 | 0.82 | ZDHHC7 (0.39) | CA1CA2SMN1; SMN2ZDHHC7ALDH1A1 | |
| SCHEMBL21707117 | 0.82 | CA1 (0.37) | CA1CA2SMN1; SMN2ZDHHC7ALDH1A1 | |
| SCHEMBL23130402 | 0.80 | MME (0.36) | CA1CA2SMN1; SMN2ALDH1A1TSHR | |
| SCHEMBL23130417 | 0.77 | — | — | |
| SCHEMBL23130162 | 0.76 | GAA (0.38) | ALDH1A1TSHRMAPK1GAA | |
| SCHEMBL4430069 | 0.75 | CA1 (0.45) | CA1CA2SMN1; SMN2ZDHHC7ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140142199-A1 | ABSORBABLE BRANCHED POLYESTERS AND POLYURETHANES | BEZWADA BIOMEDICAL, LLC | 2014-05-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140142199-A1 | ABSORBABLE BRANCHED POLYESTERS AND POLYURETHANES | SI, MGAM, BPHL | CA1 2642/4885CA2 2860/4885SMN1; SMN2 2944/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.